Literature DB >> 20381669

Value of tissue Doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure.

Rutger J Van Bommel1, Claudia Ypenburg, C Jan Willem Borleffs, Victoria Delgado, Nina Ajmone Marsan, Matteo Bertini, Eduard R Holman, Martin J Schalij, Jeroen J Bax.   

Abstract

Several studies have demonstrated a relation between left ventricular (LV) dyssynchrony and response to cardiac resynchronization therapy (CRT). Many methods of determining LV dyssynchrony have been proposed, including a value of 65 ms as assessed by tissue Doppler imaging. The aim of the present validation study was to prospectively test the predictive accuracy of the 65-ms cutoff for LV dyssynchrony in a large cohort of patients with heart failure undergoing CRT. The study included 361 patients who had undergone CRT. The clinical and echocardiographic parameters were assessed at baseline and at 6 months of follow-up. The clinical response was defined as an improvement of > or = 1 New York Heart Association class, and the echocardiographic response was defined as a reduction in LV end-systolic volume of > or = 15%. At 6 months of follow-up, 259 patients (72%) had a clinical response and 187 patients (52%) had an echocardiographic response. The patients with a response had more LV dyssynchrony than did those without a response (91 + or - 49 ms vs 50 + or - 44 ms for the clinical response and 101 + or - 46 ms vs 55 + or - 45 ms for the echocardiographic response). On multivariate analysis, LV dyssynchrony remained predictive of the response, independent of other characteristics. In conclusion, LV dyssynchrony of > or = 65 ms was an independent predictor of both the clinical and the echocardiographic response in patients with heart failure who underwent CRT in this validation study. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20381669     DOI: 10.1016/j.amjcard.2009.12.018

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony.

Authors:  Dominique Auger; Gabe B Bleeker; Matteo Bertini; See H Ewe; Rutger J van Bommel; Tomasz G Witkowski; Arnold C T Ng; Lieselot van Erven; Martin J Schalij; Jeroen J Bax; Victoria Delgado
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

Review 2.  Cardiac resynchronization therapy: the issue of non-response.

Authors:  Luigi Padeletti; Alessandro Paoletti Perini; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

3.  Robust and automatic diagnosis of the intraventricular mechanical dyssynchrony for the left ventricle in cardiac magnetic resonance images.

Authors:  Zhenzhou Wang
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-03-27       Impact factor: 2.924

Review 4.  Sex differences in device therapy for heart failure: utilization, outcomes, and adverse events.

Authors:  Naomi D Herz; Joseph Engeda; Robbert Zusterzeel; William E Sanders; Kathryn M O'Callaghan; David G Strauss; Samantha B Jacobs; Kimberly A Selzman; Ileana L Piña; Daniel A Caños
Journal:  J Womens Health (Larchmt)       Date:  2015-03-20       Impact factor: 2.681

Review 5.  Electromechanical dyssynchrony and resynchronization of the failing heart.

Authors:  Jonathan A Kirk; David A Kass
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

6.  QRS duration versus morphology and survival after cardiac resynchronization therapy.

Authors:  Mand J H Khidir; Victoria Delgado; Nina Ajmone Marsan; Martin J Schalij; Jeroen J Bax
Journal:  ESC Heart Fail       Date:  2016-12-01

7.  Clinical implication of mechanical dyssynchrony in heart failure.

Authors:  Qing Zhang; Cheuk-Man Yu
Journal:  J Cardiovasc Ultrasound       Date:  2012-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.